Allspring Global Investments Holdings LLC Raises Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Allspring Global Investments Holdings LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 201,812 shares of the exchange traded fund’s stock after buying an additional 20,734 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in SPDR S&P Biotech ETF were worth $18,020,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of XBI. Roundview Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 275.4% in the first quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock worth $683,000 after buying an additional 5,575 shares during the last quarter. U.S. Capital Wealth Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $222,000. Synovus Financial Corp raised its holdings in SPDR S&P Biotech ETF by 559.1% in the 1st quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock worth $1,390,000 after purchasing an additional 13,116 shares during the period. Vontobel Holding Ltd. raised its holdings in SPDR S&P Biotech ETF by 6.7% in the 1st quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock worth $575,000 after purchasing an additional 400 shares during the period. Finally, Sequoia Financial Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 17.6% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock worth $201,000 after purchasing an additional 334 shares during the period.

SPDR S&P Biotech ETF Trading Down 3.4 %

NYSEARCA XBI opened at $88.15 on Monday. The stock has a market capitalization of $6.76 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The stock has a 50-day moving average of $93.99 and a 200 day moving average of $83.95.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.